Evidence map›Paper›PMID 26101913›Full record

ArticleOncotarget2015

Spontaneously-forming spheroids as an in vitro cancer cell model for anticancer drug screening.

Maria A Theodoraki, Celso O Rezende, Oraphin Chantarasriwong, Adriana D Corben, Emmanuel A Theodorakis, Mary L Alpaugh

Open access · diamondAbstract read
In one paragraph

Article in Oncotarget, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
3.2field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 57 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Generation of a Perfusable 3D Lung Cancer Model by Digital Light Processing.International journal of molecular sciences · 2023
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. 3D Tumor Spheroid Models for In Vitro Therapeutic Screening of Nanoparticles.Advances in experimental medicine and biology · 2021
    Article
  13. Gambogic acid: A shining natural compound to nanomedicine for cancer therapeutics.Biochimica et biophysica acta. Reviews on cancer · 2020
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Maria A TheodorakiDepartment of Biology, Arcadia University, Philadelphia, PA, USA.
Celso O RezendeDepartment of Chemistry and Biochemistry, University of California - San Diego, La Jolla, CA, USA.
Oraphin ChantarasriwongDepartment of Chemistry and Biochemistry, University of California - San Diego, La Jolla, CA, USA.
Adriana D CorbenDepartment of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Emmanuel A TheodorakisDepartment of Chemistry and Biochemistry, University of California - San Diego, La Jolla, CA, USA.
Mary L AlpaughDepartment of Chemistry and Biochemistry, University of California - San Diego, La Jolla, CA, USA.
University of California, San Diego · USArcadia University · USMemorial Sloan Kettering Cancer Center · US

Funding

Chemical Biology of Caged Garcinia XanthonesR01CA133002 · NCI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI THEODORAKIS, EMMANUEL A · 2008 to 2012
$1.3M
NCI NIH HHS CA 133002NCI NIH HHS R01 CA133002
6 · The paper itself

Abstract

The limited translational value in clinic of analyses performed on 2-D cell cultures has prompted a shift toward the generation of 3-dimensional (3-D) multicellular systems. Here we present a spontaneously-forming in vitro cancer spheroid model, referred to as spheroids(MARY-X), that precisely reflects the pathophysiological features commonly found in tumor tissues and the lymphovascular embolus. In addition, we have developed a rapid, inexpensive means to evaluate response following drug treatment where spheroid dissolution indices from brightfield image analyses are used to construct dose-response curves resulting in relevant IC50 values. Using the spheroids(MARY-X) model, we demonstrate the unique ability of a new class of molecules, containing the caged Garcinia xanthone (CGX) motif, to induce spheroidal dissolution and apoptosis at IC50 values of 0.42 +/-0.02 μM for gambogic acid and 0.66 +/-0.02 μM for MAD28. On the other hand, treatment of spheroids(MARY-X) with various currently approved chemotherapeutics of solid and blood-borne cancer types failed to induce any response as indicated by high dissolution indices and subsequent poor IC50 values, such as 7.8 +/-3.1 μM for paclitaxel. Our studies highlight the significance of the spheroids(MARY-X) model in drug screening and underscore the potential of the CGX motif as a promising anticancer pharmacophore.

Indexed as

Amino Acid MotifsAnimalsAntineoplastic AgentsApoptosisCell Line, TumorDrug Evaluation, PreclinicalDrug Screening Assays, AntitumorGarciniaHumansImmunohistochemistryInhibitory Concentration 50Magnetic Resonance SpectroscopyMicroscopy, ConfocalMicroscopy, FluorescenceNeoplasmsNeoplasm TransplantationAntineoplastic Agentsgambogic acidXanthonesbreast cancerdrug screeninggarcinia xanthone motif (CGX)lymphovascular embolus (LVE)natural products

Identifiers

PMID26101913
PMCPMC4673263
OpenAlexW1882828593

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.